The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Crockett Thomas Andrew since 2019.
This trader's CIK number is 1690920.
At the time of last reporting, Crockett Thomas Andrew was the CEO of Kalvista Pharmaceuticals, Inc.. (stock ticker symbol KALV).
Also see all insider trading activities at Kalvista Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | KALV | 0 | $0 | 93,244 | $1,392,109 | 54,415 | $0 |
| 2023 | KALV | 0 | $0 | 72,010 | $750,302 | 92,664 | $0 |
| 2022 | KALV | 0 | $0 | 11,785 | $180,400 | 5,805 | $0 |
| 2021 | KALV | 0 | $0 | 60,000 | $1,506,010 | 0 | $0 |
| 2020 | KALV | 0 | $0 | 40,000 | $720,350 | 0 | $0 |
| 2019 | KALV | 0 | $0 | 43,000 | $880,527 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-02-17 | KALV | Option Ex | 54,415 | .00 | 0 |
| 2024-02-20 | KALV | Sale | 24,888 | 14.12 | 351,294 |
| 2024-02-14 | KALV | Sale | 58,356 | 15.01 | 875,865 |
| 2024-02-01 | KALV | Sale | 10,000 | 16.50 | 164,950 |
| 2023-12-27 | KALV | Sale | 30,000 | 12.02 | 360,450 |
| 2023-11-20 | KALV | Sale | 14,807 | 8.23 | 121,846 |
| 2023-11-17 | KALV | Option Ex | 33,583 | .00 | 0 |
| 2023-08-18 | KALV | Sale | 14,876 | 10.73 | 159,604 |
| 2023-08-17 | KALV | Option Ex | 33,582 | .00 | 0 |
| 2023-05-17 | KALV | Option Ex | 12,750 | .00 | 0 |
| 2023-05-18 | KALV | Sale | 5,627 | 10.14 | 57,080 |
| 2023-02-17 | KALV | Option Ex | 12,749 | .00 | 0 |
| 2023-02-17 | KALV | Sale | 6,700 | 7.66 | 51,322 |
| 2022-11-17 | KALV | Option Ex | 5,805 | .00 | 0 |
| 2022-11-18 | KALV | Sale | 1,785 | 5.44 | 9,710 |
| 2022-03-09 | KALV | Sale | 10,000 | 17.07 | 170,690 |
| 2021-10-01 | KALV | Sale | 10,000 | 17.18 | 171,840 |
| 2021-07-01 | KALV | Sale | 10,000 | 24.12 | 241,170 |
| 2021-06-17 | KALV | Sale | 1,067 | 30.04 | 32,050 |
| 2021-06-09 | KALV | Sale | 8,933 | 30.05 | 268,481 |
| 2021-04-01 | KALV | Sale | 10,000 | 27.27 | 272,720 |
| 2021-02-23 | KALV | Sale | 10,000 | 33.48 | 334,829 |
| 2021-01-04 | KALV | Sale | 10,000 | 18.49 | 184,920 |
| 2020-10-20 | KALV | Sale | 15,994 | 17.64 | 282,134 |
| 2020-10-21 | KALV | Sale | 22,545 | 18.34 | 413,362 |
| 2020-10-16 | KALV | Sale | 1,261 | 17.01 | 21,444 |
| 2020-02-05 | KALV | Sale | 200 | 17.05 | 3,410 |
| 2019-12-20 | KALV | Sale | 2,300 | 17.02 | 39,150 |
| 2019-12-12 | KALV | Sale | 100 | 17.00 | 1,700 |
| 2019-12-13 | KALV | Sale | 2,200 | 17.06 | 37,536 |
| 2019-12-16 | KALV | Sale | 5,400 | 17.06 | 92,118 |
| 2019-07-15 | KALV | Sale | 10,000 | 17.04 | 170,410 |
| 2019-04-15 | KALV | Sale | 10,000 | 25.34 | 253,420 |
| 2019-03-14 | KALV | Sale | 3,000 | 30.16 | 90,483 |
| 2019-01-14 | KALV | Sale | 10,000 | 19.57 | 195,710 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Crockett Thomas Andrew (CEO of Kalvista Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.